How the tumor neighborhood affects low-grade glioma turning into a more dangerous cancer

Understanding the role of tumor microenvironment in low grade glioma progression to malignancy

NIH-funded research California Institute of Technology · NIH-11174518

Researchers will map cells and molecules inside low-grade glioma tumors to find signs that predict which tumors in people may become malignant.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionCalifornia Institute of Technology NIH-funded
Lab location1 site (Pasadena, United States)
Project IDNIH-11174518 on NIH RePORTER

What this research studies

From the patient's perspective, teams at Caltech and UCLA will build a detailed map of low-grade glioma tumors using pieces of tumor tissue collected from patients. They will use advanced spatial methods to measure thousands of RNAs, multiple proteins, and DNA changes in each sample to see how tumor cells and surrounding cells are arranged and behave. The project compares tumors that later became aggressive with those that stayed indolent to find patterns that mark higher risk. The work uses about 200 human tumor samples from the UCLA Brain Tumor Translation Resource and high-sensitivity seqFISH and multiplexed assays to create an integrated atlas.

Who could benefit from this research

Good fit: Ideal candidates are people diagnosed with low-grade glioma who can donate tumor tissue or participate in related follow-up studies at participating centers.

Not a fit: People without low-grade glioma or those unable to provide tumor samples or access participating centers are unlikely to be eligible or to get direct benefit from this project.

Why it matters

Potential benefit: If successful, this could help doctors identify which low-grade gliomas are likely to become aggressive and point to ways to prevent malignant transformation.

How similar studies have performed: Spatial and single-cell mapping approaches have provided useful tumor biology insights in other cancers, but applying this specific multi-modal spatial atlas to predict low-grade glioma progression is relatively new.

Where this research is happening

Pasadena, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Brain CancerCancers
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.